Literature DB >> 9018256

Pilot study of the oral omeprazole test for reflux laryngitis.

D C Metz1, M L Childs, C Ruiz, G S Weinstein.   

Abstract

BACKGROUND: Gastroesophageal reflux disease occasionally presents with laryngeal symptoms. Such patients are often referred for a gastroenterology evaluation. This study was designed to determine whether an empiric trial of high-dose omeprazole therapy could reliably identify patients with reflux laryngitis and thus obviate the need for a gastroenterology workup.
METHODS: Patients were evaluated with a history, physical examination, esophageal manometry, upper endoscopy, and 24-hour pH-metry for determination of the presence of absence of underlying gastroesophageal reflux disease and then received an empiric trial of oral omeprazole therapy (20 mg twice daily for 1 month). A positive omeprazole test result was defined as resolution of all laryngeal symptoms on completion of the empiric trial of therapy.
RESULTS: Two patients were classified as having no reflux, and eight were classified as having reflux. Omeprazole test results were positive in six patients. Five of six had reflux, but one patient had no evidence for reflux. Omeprazole test results were negative in four patients. Three of four had reflux, and one did not. Despite the absence of antisecretory therapy, laryngeal symptoms did not recur in either patient without reflux during follow-up. Laryngeal symptoms were managed in two of the three patients with reflux who had negative omeprazole test results and who were using inhalers in combination with histamine H2 receptor antagonist therapy for their reflux disease. One patient with reflux who had a negative omeprazole test result responded to higher doses of omeprazole, and the five patients with reflux who had positive omeprazole test results all responded to continuation of omeprazole.
CONCLUSIONS: The omeprazole test may be useful in confirming the suspicion of reflux laryngitis in patients suspected of having this disease after an otolaryngology evaluation. However, there is a potential for false-positive and false-negative test results. A gastroenterology evaluation may aid in the identification of false-positive test results by documenting the absence of reflux in certain responders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018256     DOI: 10.1016/s0194-5998(97)70350-4

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  11 in total

Review 1.  Atypical manifestations of gastroesophageal reflux disease.

Authors:  Michael F Vaezi
Journal:  MedGenMed       Date:  2005-10-27

2.  Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study.

Authors:  Fabio Pace; Gabriele Riegler; Annalisa de Leone; Patrizia Dominici; Enzo Grossi
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

Review 3.  Supra-oesophageal manifestations of gastro-oesophageal reflux disease.

Authors:  Manuel Rodríguez-Téllez
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.

Authors:  Christopher Hom; Michael F Vaezi
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

5.  Clinical manifestations and role of proton pump inhibitors in the management of laryngopharyngeal reflux.

Authors:  Suhail Amin Patigaroo; S F Hashmi; Syed Abrar Hasan; M R Ajmal; Nazia Mehfooz
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-30

6.  Reflux-induced laryngitis (laryngopharyngeal reflux).

Authors:  Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

7.  Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.

Authors:  Fabio Baldi; Roberta Cappiello; Carlotta Cavoli; Stefania Ghersi; Francesco Torresan; Enrico Roda
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

8.  Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice.

Authors:  Vicente Garrigues; Lirios Gisbert; Guillermo Bastida; Vicente Ortiz; Inmaculada Bau; Pilar Nos; Julio Ponce
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

9.  Effect of stellate ganglion block on laryngopharyngeal reflux disease.

Authors:  Ji Won Chung; Hye Jung Chun; Mi Soon Lee; Ki Ryang Ahn; Chun Sook Kim; Kyu Sik Kang; Sie Hyeon Yoo; Jin Hun Chung; Nan-Seol Kim; Yong Han Seo; Hyung Youn Gong; Yong Man Lee
Journal:  Korean J Anesthesiol       Date:  2013-05-24

10.  Lung diffusion capacity in children with respiratory symptoms and untreated GERD.

Authors:  Mirjana Mirić; Mirjana Turkalj; Boro Nogalo; Damir Erceg; Marija Perica; Davor Plavec
Journal:  Med Sci Monit       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.